Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Rossari Biotech Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 2 October 2026, 9:22 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price428₹ per share
Reported P/E15.7Times
Book value per share241₹ per share
Reported ROCE13.3 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 2 October 2026, 9:22 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap2,368 Cr.
Current Price428
High / Low691/373
Stock P/E15.7
Book Value241
Dividend Yield0.12 %
ROCE13.3 %
ROE10.8 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Rossari Biotech Ltd 2,368 Cr. 428 691/37315.7 2410.12 %13.3 %10.8 % 2.00
Panama Petrochem Ltd 2,947 Cr. 487 600/2296.15 2430.62 %19.2 %15.6 % 2.00
Thirumalai Chemicals Ltd 1,763 Cr. 146 294/143 1300.00 %3.15 %11.8 % 1.00
Camlin Fine Sciences Ltd 1,748 Cr. 91.0 212/89.1 54.20.00 %4.78 %3.75 % 1.00
Grauer & Weil (India) Ltd 3,709 Cr. 81.8 89.8/49.723.2 23.90.61 %20.6 %15.2 % 1.00
Industry Average12,353.32 Cr1,090.6245.38191.320.56%12.24%9.76%6.41

All Competitor Stocks of Rossari Biotech Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 411483464473490498513580544586582685697
Expenses 353420400409425432448510476514513608617
Operating Profit 58646464656665696872697781
OPM % 14%13%14%13%13%13%13%12%12%12%12%11%12%
Other Income 21411112221204
Interest 65434456668911
Depreciation 14151516151518181818202426
Profit before tax 39454846474842484650436448
Tax % 26%26%28%25%26%27%25%28%27%26%23%28%26%
Net Profit 29333434353532343437334635
EPS in Rs 5.305.976.236.186.326.395.736.226.076.665.928.306.34

Last Updated: September 29, 2026, 6:01 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 30, 2026, 9:21 pm

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 5166007091,4831,6561,8312,0802,3962,550
Expenses 4384955861,2991,4331,5811,8152,1102,251
Operating Profit 78105124184223250265286299
OPM % 15%17%17%12%13%14%13%12%12%
Other Income 149136852426
Interest 343132219182934
Depreciation 121723486360677987
Profit before tax 6388107136144178185203204
Tax % 28%26%25%28%26%26%26%26%
Net Profit 46658098107131136149151
EPS in Rs 103.8212.8615.4517.7419.4523.6624.6326.9427.22
Dividend Payout % 0%4%3%3%3%2%2%2%

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)41.30%23.08%22.50%9.18%22.43%3.82%9.56%
Change in YoY Net Profit Growth (%)0.00%-18.23%-0.58%-13.32%13.25%-18.61%5.74%

Rossari Biotech Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2019-2020 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:Not available
5 Years:28%
3 Years:12%
TTM:12%
Compounded Profit Growth
10 Years:Not available
5 Years:16%
3 Years:12%
TTM:-1%
Stock Price CAGR
10 Years:Not available
5 Years:-5%
3 Years:-14%
1 Year:-29%
Return on Equity
10 Years:Not available
5 Years:14%
3 Years:13%
Last Year:12%

Last Updated: September 5, 2025, 1:10 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 30, 2026, 9:21 pm

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 410101111111111
Reserves 1192773987949041,0371,1741,322
Borrowings 8670874119218436
Other Liabilities 118118152442375401482505
Total Liabilities 2504715611,2551,3641,5671,8862,274
Fixed Assets 7494181607585578598784
CWIP 322011647140173
Investments 01803651638462
Other Assets 1733383796117128801,0631,254
Total Assets 2504715611,2551,3641,5671,8862,274
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 715748291524313765
Cash from Investing Activity + -37-190-37-299-181-103-183-220
Cash from Financing Activity + -29157-25292611665186
Net Cash Flow 523-142232-441931
Free Cash Flow 27-19-8-7120-83-21-175
CFO/OP 118%74%64%43%89%39%74%47%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow27.00-19.00-8.00-7.00120.00-83.00-21.00-175.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 61577475788583
Inventory Days 59577563598090
Days Payable 1149510461566273
Cash Conversion Cycle 619467680103101
Working Capital Days 23226062497069
ROCE %38%29%24%18%18%16%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 68.35%68.34%68.32%68.32%68.27%68.19%68.18%68.18%68.18%68.15%68.15%68.14%
FIIs 5.74%4.14%4.02%3.83%3.74%3.74%3.98%3.48%2.70%2.32%2.18%2.03%
DIIs 17.68%18.06%17.74%16.87%17.34%17.47%17.59%17.84%18.18%18.25%18.21%14.64%
Public 8.23%9.45%9.90%10.98%10.64%10.60%10.24%10.50%10.95%11.25%11.46%15.19%
No. of Shareholders 95,2001,00,42398,8591,00,47597,18895,73592,85291,79191,38789,24986,97287,580
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Small Cap Fund 2,016,342 0.33 113.82,016,7982025-12-08 04:48:22-0.02%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 24.6623.6719.4617.8115.56
Diluted EPS (Rs.) 24.6323.6219.3817.7015.47
Cash EPS (Rs.) 36.5734.5630.6826.1919.73
Book Value[Excl.RevalReserv]/Share (Rs.) 214.12189.65165.93146.2578.72
Book Value[Incl.RevalReserv]/Share (Rs.) 214.12189.65165.93146.2578.72
Revenue From Operations / Share (Rs.) 375.74331.35300.22269.36136.60
PBDIT / Share (Rs.) 48.6046.5641.4335.5025.47
PBIT / Share (Rs.) 36.4935.6330.0226.7721.07
PBT / Share (Rs.) 33.2732.1225.9724.4720.49
Net Profit / Share (Rs.) 24.4623.6219.2717.4615.34
NP After MI And SOA / Share (Rs.) 24.6323.6619.4517.7415.45
PBDIT Margin (%) 12.9314.0513.7913.1718.64
PBIT Margin (%) 9.7110.759.999.9315.42
PBT Margin (%) 8.859.698.659.0815.00
Net Profit Margin (%) 6.507.126.416.4811.22
NP After MI And SOA Margin (%) 6.557.136.476.5811.30
Return on Networth / Equity (%) 11.5012.4711.7112.1319.62
Return on Capital Employeed (%) 14.8517.1516.2215.3126.61
Return On Assets (%) 7.198.317.847.7714.29
Long Term Debt / Equity (X) 0.080.030.030.000.00
Total Debt / Equity (X) 0.150.100.080.010.00
Asset Turnover Ratio (%) 1.201.251.261.631.37
Current Ratio (X) 1.941.992.082.072.36
Quick Ratio (X) 1.281.321.541.421.73
Inventory Turnover Ratio (X) 6.535.225.706.805.66
Dividend Payout Ratio (NP) (%) 2.022.112.562.813.16
Dividend Payout Ratio (CP) (%) 1.351.441.611.882.46
Earning Retention Ratio (%) 97.9897.8997.4497.1996.84
Cash Earning Retention Ratio (%) 98.6598.5698.3998.1297.54
Interest Coverage Ratio (X) 15.1113.2810.2415.4444.20
Interest Coverage Ratio (Post Tax) (X) 8.607.745.768.6027.62
Enterprise Value (Cr.) 3475.133801.343233.014985.625300.00
EV / Net Operating Revenue (X) 1.672.081.953.367.47
EV / EBITDA (X) 12.9114.7814.1525.5140.08
MarketCap / Net Operating Revenue (X) 1.612.041.983.397.60
Retention Ratios (%) 97.9797.8897.4397.1896.83
Price / BV (X) 2.823.563.596.2513.18
Price / Net Operating Revenue (X) 1.612.041.983.397.60
EarningsYield 0.040.030.030.010.01
Advertisements
Explore Industry-wise Company financial data